The research team of Maria Mora Pinzon, MD, MS, FACPM, is collaborating with a research team from the Milwaukee-based United Community Center (UCC) and dementia experts from UCC Latino Geriatric Center to develop a new educational curriculum for University of Wisconsin-Madison medical students.
WAI News
Dr. Walaszek named associate dean for faculty affairs and development
Congratulations Dr. Walaszek!
The Amazing Grace Chorus invites new members to join
The Amazing Grace Chorus, a community program hosted by the Wisconsin Alzheimer’s Institute Regional Milwaukee Office, welcomes new members to join the new program.
Dr. Mora Pinzon helps create ACPM brain health toolkit for healthcare providers
This toolkit provides a guide with illustrative examples to assist preventive medicine physicians and related partners to educate patients on Alzheimer’s disease and related dementias, reduce risk factors related to dementia.
UW-Madison Alzheimer’s disease research program featured in Madison Magazine
University of Wisconsin–Madison Alzheimer’s disease research programs are featured in the August 2024 issue of Madison Magazine.
IEA Innovation fund announces first round of funding in support of UW–Madison Alzheimer’s disease research programs
The Initiative to End Alzheimer’s (IEA) Innovation fund’s goal is to advance promising new ideas in UW–Madison Alzheimer’s Disease (AD) research and programming, enhance resources available to researchers, program leads and staff and respond to innovative and emerging needs of this area of medicine. The IEA Innovation Fund aims to be a key driver of novel ideas and entrepreneurial energy for both the Wisconsin ADRC and WAI.
FDA approves Alzheimer’s disease drug donanemab
On July 2, 2024, the U.S. Food and Drug Administration (FDA) approved Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease.
The Wisconsin Department of Health Services announces 2024-2028 State Dementia Plan
Wisconsin Alzheimer’s Institute staff and leaders helped lead development of state plan
Dr. Art Walaszek discusses DICE toolkit in national news outlets
DICE stands for Describe, Investigate, Create, Evaluate; a process for caregivers to identify underlying reasons for behaviors in a person with dementia and methods to address them, often without medications.
WRAP data used in study finding a distinct, genetic form of Alzheimer’s disease
The researchers examined pathological data from 3,297 brain donors and biomarkers and clinical data from over 10,000 people, including participants from the Wisconsin Registry for Alzheimer’s Prevention and five large multicenter cohorts in Europe and the US.